English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 22, 2026

Study finds statins may cause muscle side effects by activating inflammatory signals
+ Pharmaceuticals
Patient Daily | Jun 22, 2026

Analyst discusses potential health and social care reforms under Andy Burnham premiership
+ Pharmaceuticals
Patient Daily | Jun 22, 2026

IL1RAP-targeted therapy moves toward clinical trial for pancreatic cancer at Sylvester Center
+ Pharmaceuticals
Patient Daily | Jun 22, 2026

O2 trials new technology to improve call clarity for users with hearing loss
+ Pharmaceuticals
Patient Daily | Jun 22, 2026

Amazon study links land use and poverty to vector-borne disease clusters
+ Pharmaceuticals
Patient Daily | Jun 22, 2026

Nuvectis secures rights to two Haisco late-stage drugs in $1.4 billion deal
+ Pharmaceuticals
Patient Daily | Jun 22, 2026

Study links psychological traits to distinct molecular subtypes in Alzheimer’s dementia
+ Pharmaceuticals
Patient Daily | Jun 22, 2026

Researchers identify PRDM16 as key regulator in human cardiac aging process

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation